Vimarsana
Biggest News Aggregation in the World

Study Support Continued Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Support Continued Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Support Continued Development Today - Breaking & Trending Today

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference - Vimarsana News

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

Published: September 1, 2023

BOSTON, Sept. 01, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...

Source: marketscreener.com
Related Topics:
District Of ColumbiaUnited StatesNew YorkJames McarthurSarah SuttonAshling HollandLaurence WattsPreclinical DevelopmentPepgen IncPreclinical Development At PepgenGilmartin GroupMyotonic Dystrophy Foundation Annual ConferenceStudy Support Continued DevelopmentHead Of Clinical DevelopmentDystrophy Foundation Annual ConferenceNeuromuscular Disease MeetingAnnual Global Investment ConferenceInvestor RelationsIndustry Updates PartPotomac BallroomMichelle MellionSenior Vice PresidentSupport PhaseContinue Evaluating SafetyDuchenne Muscular Dystrophy
PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference - PepGen (NASDAQ:PEPG) - Vimarsana News

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference - PepGen (NASDAQ:PEPG)

Published: September 1, 2023

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of

Source: benzinga.com
Related Topics:
District Of ColumbiaUnited StatesNew YorkAshling HollandJames McarthurLaurence WattsMyotonic Dystrophy Foundation Annual ConferencePreclinical Development At PepgenPreclinical DevelopmentPepgen IncHead Of Clinical DevelopmentStudy Support Continued DevelopmentGilmartin GroupDystrophy Foundation Annual ConferenceNeuromuscular Disease MeetingAnnual Global Investment ConferenceInvestor RelationsIndustry Updates PartPotomac BallroomMichelle MellionSenior Vice PresidentSupport PhaseContinue Evaluating SafetyDuchenne Muscular DystrophyPositive Results